abstract |
The present invention relates to a device having molecules binding to soluble tumor necrosis factor receptor 2 (sTNFR2, TNFRSFIB) immobilized on a solid support, wherein no molecules binding to soluble tumor necrosis factor receptor 1 (sTNFRl) are immobilized. Further, the present invention relates to a method for the removal of sTNFR2 from blood, plasma or a blood fraction. Moreover, the present invention relates to a molecule specifically binding to sTNFR2, but not binding to sTNFRl, for use in a method for treating the human or animal body and to blood, plasma or a blood fraction obtainable from the method of the present invention for use in a method for treating cancer. |